The results revealed that the levels of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) were significantly greater in P210-elevated CML patients (Figures 4J, K). The gene discussed is TNF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.